Sanyou Bio

company

About

Sanyou Biopharmaceuticals is contract research organization company focused on R&D and services to create innovative antibody drugs.

  • 101 - 250

Details

Last Funding Type
Series A
Industries
Biometrics,Biotechnology,Pharmaceutical
Founded date
Jan 1, 2015
Number Of Employee
101 - 250
Operating Status
Active

Sanyou Biopharmaceuticals Co., Ltd. is a leading international CRO (contract research organization) company focused on R&D and services to create innovative antibody drugs. The company has established an integrated innovative antibody drug R&D laboratory of several thousand square meters with advanced facilities in Caohejing Hi-Tech Park. During the last five years, Sanyou built and validated more than 20 core technological platforms such as: innovative antibody drug discovery, antibody engineering, in vivo and in vitro drug efficacy evaluation, stable cell line construction, and production process development.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
Sanyou Bio has raised a total of — in funding over 2 rounds. Their latest funding was raised on Aug 2, 2022 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Aug 2, 2022 Series B 1 Detail
Jun 25, 2021 Series B 2 Qianhai LH Ventures Detail
May 16, 2020 Series A 2 Shanghai ZJ Bio-Tech Technology
Haier Financial Holdings
Detail

Investors

Number of Lead Investors
Number of Investors
3
4
Sanyou Bio is funded by 4 investors. Shanghai ZJ Bio-Tech Technology and Haier Financial Holdings are the most recent investors.
Investor Name Lead Investor Funding Round
Shanghai ZJ Bio-Tech Technology Yes Series A
Haier Financial Holdings Yes Series A
Qianhai LH Ventures Series B
Seeking Capital Series B